Company Name: Novavax, Inc.

Novavax, Inc. is a clinical stage vaccine company.  The company is engaged in the development of recombinant nanoparticle vaccines and adjuvants.  The company’s pipeline includes vaccine candidates for a range of infectious diseases including:

  • Respiratory syncytial virus (RSV)
  • Seasonal influenza
  • Pandemic influenza
  • Ebola virus

Ticker Symbol: NVAX (NASDAQ)

Company Website:

Social Media:

Novavax LinkedIn

Novavax Twitter

Novavax YouTube

Headquarters: Gaithersburg, MD